These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35639541)

  • 1. Acute onset ocular myasthenia gravis after COVID-19 vaccination: correspondence.
    Mungmunpuntipantip R; Wiwanitkit V
    Orbit; 2022 Oct; 41(5):661. PubMed ID: 35639541
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to letter to the editor regarding
    Maher DI; Hogarty D; Ben Artsi E
    Orbit; 2022 Oct; 41(5):662-663. PubMed ID: 35686598
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 vaccination and myasthenia gravis.
    Arbel A; Bishara H; Barnett-Griness O; Cohen S; Najjar-Debbiny R; Gronich N; Auriel E; Saliba W
    Eur J Neurol; 2023 Dec; 30(12):3989-3990. PubMed ID: 37797299
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 vaccination and myasthenia gravis.
    Kleebayoon A; Wiwanitkit V
    Eur J Neurol; 2023 Dec; 30(12):3988. PubMed ID: 37797298
    [No Abstract]   [Full Text] [Related]  

  • 5. New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series.
    Fanella G; Baiata C; Candeloro E; Toscano G; Colnaghi S; Mauri M; Cariddi LP; Rebecchi V; Solazzo F; Banfi P; Piatti M; Ferrarese C; Versino M
    Neurol Sci; 2022 Oct; 43(10):5799-5802. PubMed ID: 35870026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute onset ocular myasthenia gravis after vaccination with the Oxford-AstraZeneca COVID-19 vaccine.
    Maher DI; Hogarty D; Ben Artsi E
    Orbit; 2023 Dec; 42(6):630-634. PubMed ID: 35499172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Vaccination and Late-Onset Myasthenia Gravis: A New Case Report and Review of the Literature.
    Virgilio E; Tondo G; Montabone C; Comi C
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature.
    Ramdas S; Hum RM; Price A; Paul A; Bland J; Burke G; Farrugia M; Palace J; Storrie A; Ho P; Standing E; Lilleker JB; Jungbluth H
    Neuromuscul Disord; 2022 Oct; 32(10):785-789. PubMed ID: 36130855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccination in myasthenia gravis: safe, but predictors of disease exacerbation yet to be determined.
    Kim S; Eun MY; Seok HY
    Neurol Sci; 2023 May; 44(5):1503-1504. PubMed ID: 36808584
    [No Abstract]   [Full Text] [Related]  

  • 10. The Clinical Course of New-Onset Ocular Myasthenia Gravis Caused by Pfizer-BioNTech COVID-19 Vaccine.
    Su WY; Lu CJ
    Acta Neurol Taiwan; 2023 Dec; 32(4)():218-222. PubMed ID: 37723915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To Be or Not To Be Vaccinated: That Is a Question in Myasthenia Gravis.
    Zhou Q; Zhou R; Yang H; Yang H
    Front Immunol; 2021; 12():733418. PubMed ID: 34603311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flare of myasthenia gravis induced by COVID-19 vaccines.
    Ishizuchi K; Takizawa T; Sekiguchi K; Motegi H; Oyama M; Nakahara J; Suzuki S
    J Neurol Sci; 2022 May; 436():120225. PubMed ID: 35290838
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of SARS-CoV-2 immunization on COVID-19 disease course in people with myasthenia gravis.
    Bakirtzis C; Boziki MK; Karakasi MV; Moysiadis T; Grigoriadis N
    Muscle Nerve; 2023 May; 67(5):412-416. PubMed ID: 36814101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of mRNA COVID-19 vaccines in patients with well-controlled myasthenia gravis.
    Gamez J; Gamez A; Carmona F
    Muscle Nerve; 2022 Nov; 66(5):612-617. PubMed ID: 36029224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational study on the safety of COVID-19 vaccination in patients with myasthenia gravis.
    Wang HY; Qiu L; Ou CY; Lin ZQ; Huang ZD; Chen P; Ma Q; Lu YR; Ran H; Liu WB
    Neurol Sci; 2023 Jul; 44(7):2239-2245. PubMed ID: 37160544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective study on the safety of COVID-19 vaccination in myasthenia gravis.
    Urra Pincheira A; Alnajjar S; Katzberg H; Barnett C; Daniyal L; Rohan R; Bril V
    Muscle Nerve; 2022 Nov; 66(5):558-561. PubMed ID: 35673960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study.
    Ruan Z; Huan X; Su Y; Tang YL; Meng DD; Ren DL; Li CH; Hao SJ; Zhao CB; Luo SS; Li ZY; Chang T
    Front Immunol; 2023; 14():1141983. PubMed ID: 37223097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of COVID-19 vaccines in patients with myasthenia gravis: A scoping review.
    Peng S; Tian Y; Meng L; Fang R; Chang W; Yang Y; Li S; Shen Q; Ni J; Zhu W
    Front Immunol; 2022; 13():1103020. PubMed ID: 36618419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
    Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and outcomes of Myasthenia Gravis associated with COVID-19 vaccines: A systematic review and pooled analysis.
    Tayebi AH; Samimisedeh P; Jafari Afshar E; Ayati A; Ghalehnovi E; Foroutani L; Abbasi Khoshsirat N; Rastad H
    Medicine (Baltimore); 2023 Oct; 102(40):e34890. PubMed ID: 37800781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.